Direxion Shares ETF Trust. Holdings as of Jul 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| DREYFUSCash or money market | 15.86% | $78.39M | 78,386,409 |
| GOLDMAN FINANCIALCash or money market | 14.83% | $73.30M | 73,297,612 |
| N/ADO | 9.63% | $47.60M | 1 |
| N/ADO | 7.30% | $36.07M | 1 |
| GOLDMAN SACHS LIQ ES FD ACash or money market | 5.35% | $26.47M | 26,472,640 |
| N/ADO | 4.85% | $23.96M | 1 |
| N/ADO | 3.87% | $19.15M | 1 |
| APOGEE THERAPEUTICS INC | 1.11% | $5.47M | 40,796 |
| ORUKA THERAPEUTICS INCORKA | 1.03% | $5.09M | 52,700 |
| DIANTHUS THERAPEUTICS INCDNTH | 0.96% | $4.72M | 44,156 |
| ERASCA INCERAS | 0.93% | $4.58M | 252,386 |
| TWIST BIOSCIENCE CORPTWST | 0.92% | $4.56M | 49,791 |
| KYMERA THERAPEUTICS INCKYMR | 0.90% | $4.46M | 43,133 |
| SPYRE THERAPEUTICS INCSYRE | 0.89% | $4.42M | 44,942 |
| REVOLUTION MEDICINES INCRVMD | 0.89% | $4.39M | 23,402 |
| CG ONCOLOGY INCCGON | 0.88% | $4.37M | 61,441 |
| PROTAGONIST THERAPEUTICS INCPTGX | 0.88% | $4.36M | 31,902 |
| PRAXIS PRECISION MEDICINES INCPRAX | 0.87% | $4.32M | 14,020 |
| REGENERON PHARMACEUTICALS INCREGN | 0.87% | $4.28M | 5,608 |
| COGENT BIOSCIENCES INCCOGT | 0.85% | $4.19M | 107,533 |
| NATERA INCNTRA | 0.84% | $4.17M | 15,588 |
| ARROWHEAD PHARMACEUTICALS INCARWR | 0.82% | $4.04M | 47,707 |
| TRAVERE THERAPEUTICS INCTVTX | 0.82% | $4.04M | 72,196 |
| ROIVANT SCIENCES LTDROIV | 0.81% | $4.03M | 118,777 |
| RELAY THERAPEUTICS INCRLAY | 0.81% | $4.02M | 213,661 |
| MODERNA INCMRNA | 0.81% | $4.02M | 73,372 |
| VAXCYTE INCPCVX | 0.81% | $4.02M | 74,294 |
| BRIDGEBIO PHARMA INCBBIO | 0.81% | $4.01M | 50,063 |
| HALOZYME THERAPEUTICS INCHALO | 0.80% | $3.95M | 47,863 |
| RHYTHM PHARMACEUTICALS INCRYTM | 0.79% | $3.91M | 39,370 |
| CYTOKINETICS INCCYTK | 0.78% | $3.88M | 50,312 |
| VIKING THERAPEUTICS INCVKTX | 0.78% | $3.86M | 121,599 |
| AMGEN INCAMGN | 0.78% | $3.85M | 9,994 |
| INCYTE CORPINCY | 0.77% | $3.83M | 32,018 |
| MIRUM PHARMACEUTICALS INCMIRM | 0.77% | $3.80M | 35,899 |
| ALKERMES PLC | 0.76% | $3.77M | 76,970 |
| TG THERAPEUTICS INCTGTX | 0.76% | $3.77M | 72,380 |
| ABBVIE INCABBV | 0.76% | $3.76M | 15,001 |
| VERTEX PHARMACEUTICALS INCVRTX | 0.75% | $3.69M | 7,744 |
| KRYSTAL BIOTECH INCKRYS | 0.75% | $3.68M | 10,801 |
| INSMED INCINSM | 0.73% | $3.62M | 36,726 |
| SCHOLAR ROCK HOLDING CORPSRRK | 0.73% | $3.62M | 76,534 |
| GILEAD SCIENCES INCGILD | 0.73% | $3.62M | 27,780 |
| BIOMARIN PHARMACEUTICAL INCBMRN | 0.73% | $3.61M | 60,076 |
| UNIQURE NV | 0.72% | $3.54M | 81,217 |
| DYNE THERAPEUTICS INCDYN | 0.72% | $3.54M | 140,706 |
| BIOGEN INCBIIB | 0.71% | $3.53M | 17,370 |
| NEUROCRINE BIOSCIENCES INCNBIX | 0.71% | $3.50M | 20,978 |
| N/ADO | 0.71% | $3.49M | 1 |
| ACADIA PHARMACEUTICALS INCACAD | 0.71% | $3.49M | 134,777 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.